(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
8.77% $ 1.240
Live Chart Being Loaded With Signals
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage...
Stats | |
---|---|
Tagesvolumen | 16 875 |
Durchschnittsvolumen | 25 898 |
Marktkapitalisierung | 60.52M |
EPS | $0.0173 ( Q2 | 2023-12-31 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-08-21 |
Last Dividend | $0.0500 ( 2024-02-21 ) |
Next Dividend | $0 ( N/A ) |
P/E |
41.33 (Sector) 0 (Industry) 0 |
ATR14 | $0 (0.00%) |
Cryosite Ltd Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Cryosite Ltd Finanzdaten
Annual | 2023 |
Umsatz: | $11.94M |
Bruttogewinn: | $6.48M (54.28 %) |
EPS: | $0.0289 |
FY | 2023 |
Umsatz: | $11.94M |
Bruttogewinn: | $6.48M (54.28 %) |
EPS: | $0.0289 |
FY | 2022 |
Umsatz: | $11.76M |
Bruttogewinn: | $6.27M (53.36 %) |
EPS: | $0.0279 |
FY | 2021 |
Umsatz: | $10.02M |
Bruttogewinn: | $5.89M (58.80 %) |
EPS: | $0.0139 |
Financial Reports:
No articles found.
Cryosite Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0100 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.0150 (N/A) |
$0 (N/A) |
$0.0500 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00500 | 2012-03-16 |
Last Dividend | $0.0500 | 2024-02-21 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | $0.140 | -- |
Avg. Dividend % Per Year | 3.74% | -- |
Score | 4.91 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.21 | |
Div. Directional Score | 9.23 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.0100 | 6.90% |
2013 | $0.0150 | 3.95% |
2014 | $0.0150 | 3.26% |
2015 | $0.0100 | 2.56% |
2016 | $0.0100 | 4.26% |
2017 | $0.00500 | 2.86% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0.0100 | 2.17% |
2023 | $0.0150 | 2.08% |
2024 | $0.0500 | 8.26% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
21 Feb 2024 | $0.0500 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
07 Sep 2023 | $0.0150 | 30 Nov -0001 | 08 Sep 2023 | 06 Oct 2023 |
15 Sep 2022 | $0.0100 | 30 Nov -0001 | 16 Sep 2022 | 14 Oct 2022 |
14 Mar 2017 | $0.00500 | 22 Feb 2017 | 15 Mar 2017 | 31 Mar 2017 |
07 Sep 2016 | $0.00500 | 24 Aug 2016 | 08 Sep 2016 | 04 Oct 2016 |
11 Mar 2016 | $0.00500 | 24 Feb 2016 | 15 Mar 2016 | 31 Mar 2016 |
08 Sep 2015 | $0.00500 | 26 Aug 2015 | 10 Sep 2015 | 01 Oct 2015 |
13 Mar 2015 | $0.00500 | 25 Feb 2015 | 17 Mar 2015 | 31 Mar 2015 |
08 Sep 2014 | $0.0100 | 28 Aug 2014 | 10 Sep 2014 | 24 Sep 2014 |
17 Mar 2014 | $0.00500 | 26 Feb 2014 | 21 Mar 2014 | 04 Apr 2014 |
23 Sep 2013 | $0.0100 | 29 Aug 2013 | 27 Sep 2013 | 23 Oct 2013 |
18 Mar 2013 | $0.00500 | 26 Feb 2013 | 22 Mar 2013 | 05 Apr 2013 |
28 Sep 2012 | $0.00500 | 23 Aug 2012 | 05 Oct 2012 | 23 Oct 2012 |
16 Mar 2012 | $0.00500 | 28 Feb 2012 | 22 Mar 2012 | 05 Apr 2012 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
EZL.AX | Dividend Royal | 2024-02-02 | Semi-Annually | 24 | 11.64% | 8.24 |
GRR.AX | Dividend Royal | 2024-03-12 | Semi-Annually | 14 | 11.88% | 7.99 |
RKN.AX | Dividend Royal | 2023-08-31 | Annually | 22 | 15.73% | 7.24 |
TWR.AX | Dividend King | 2024-06-12 | Annually | 25 | 5.98% | 7.21 |
YAL.AX | Dividend Royal | 2024-03-12 | Annually | 7 | 12.76% | 7.18 |
SHM.AX | Dividend Royal | 2024-03-14 | Semi-Annually | 9 | 14.97% | 7.14 |
HZN.AX | Dividend Royal | 2024-04-18 | Semi-Annually | 4 | 18.99% | 7.06 |
BHP.AX | Dividend Royal | 2024-03-07 | Semi-Annually | 37 | 6.46% | 6.97 |
CDD.AX | Ex Dividend King | 2024-05-24 | Annually | 21 | 91.43% | 6.79 |
KSL.AX | Dividend Royal | 2024-03-05 | Semi-Annually | 9 | 9.58% | 6.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.125 | 1.500 | 7.50 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0711 | 1.200 | 7.63 | 9.16 | [0 - 0.3] |
returnOnEquityTTM | 0.555 | 1.500 | 4.94 | 7.41 | [0.1 - 1] |
payoutRatioTTM | 0.464 | -1.000 | 5.36 | -5.36 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.85 | 3.88 | [1 - 3] |
quickRatioTTM | 1.942 | 0.800 | 3.28 | 2.63 | [0.8 - 2.5] |
cashRatioTTM | 1.458 | 1.500 | 3.01 | 4.51 | [0.2 - 2] |
debtRatioTTM | 0.114 | -1.500 | 8.10 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 15.39 | 1.000 | 5.41 | 5.41 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0493 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0405 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.873 | -1.500 | 6.51 | -9.76 | [0 - 2.5] |
grossProfitMarginTTM | 0.550 | 1.000 | 4.17 | 4.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.138 | 1.000 | 9.23 | 9.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.952 | 1.000 | 5.82 | 5.82 | [0.2 - 2] |
assetTurnoverTTM | 0.569 | 0.800 | 9.54 | 7.63 | [0.5 - 2] |
Total Score | 11.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.16 | 1.000 | 6.35 | 0 | [1 - 100] |
returnOnEquityTTM | 0.555 | 2.50 | 6.75 | 7.41 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0405 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.42 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0493 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.464 | 1.500 | 5.36 | -5.36 | [0 - 1] |
pegRatioTTM | 3.38 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.191 | 1.000 | 7.73 | 0 | [0.1 - 0.5] |
Total Score | 7.21 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cryosite Ltd
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.